Auditory evoked potentials remain abnormal after CPAP treatment in patients with severe obstructive sleep apnoea

被引:15
|
作者
Vakulin, Andrew [1 ,2 ]
Catcheside, Peter G. [1 ,2 ,5 ]
Baulk, Stuart D. [3 ]
Antic, Nick A. [1 ,5 ]
van den Heuvel, Cameron J. [6 ]
Banks, Siobhan [4 ]
McEvoy, R. Doug [1 ,2 ,5 ]
机构
[1] Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Adelaide, SA 5041, Australia
[2] Univ Adelaide, Sch Med Sci, Discipline Physiol, Adelaide, SA 5005, Australia
[3] Integrated Safety Support, Adelaide, SA 5071, Australia
[4] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5000, Australia
[5] Flinders Univ S Australia, Dept Med, Bedford Pk, SA 5041, Australia
[6] Univ Adelaide, Womens & Childrens Hosp, Childrens Res Ctr, Adelaide, SA 5006, Australia
基金
英国医学研究理事会;
关键词
Obstructive sleep apnoea; ERP; CPAP; EVENT-RELATED POTENTIALS; SIMULATED DRIVING PERFORMANCE; POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; BREATHING DISORDERS; BRAIN-DYSFUNCTION; P300; LATENCIES; DEPRIVATION; ADULTS; WAKEFULNESS;
D O I
10.1016/j.clinph.2011.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the effects of 3 months of optimal CPAP treatment on auditory event related potentials (AERP) in patients with severe obstructive sleep apnoea (OSA) compared with healthy controls. Methods: Auditory odd-ball related N1, P2, N2 and P3 AERP components were assessed in 9 severe OSA subjects and 9 healthy controls at baseline evaluation and at similar to 3 months follow-up in both groups, with OSA subjects treated with continuous positive air-way pressure (CPAP) during this period. Results: Severe OSA subjects showed significantly delayed, P2, N2 and P3 latencies, and significantly different P2 and P3 amplitudes compared to controls at baseline (group effect, all p < 0.05). At follow-up evaluation P3 latency shortened in treated OSA patients but remained prolonged compared to controls (group by treatment interaction, p < 0.05) despite high CPAP compliance (6 h/night). The earlier AERP (P2 and N2) components did not change in either controls or OSA patients at follow-up and remained different in patients versus controls. Conclusions: This study demonstrates that in severe OSA patients AERP responses show minimal or no improvement and remain abnormal following 3 months of optimal CPAP treatment. Significance: Persistent cortical sensory processing abnormalities despite treatment in severe OSA may have implications for daytime neurobehavioral performance and safety in OSA patients. AERP responses may help identify residual performance deficits and risks. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 50 条
  • [31] C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy
    Schiza, Sophia E.
    Mermigkis, Charalampos
    Panagiotis, Panagou
    Bouloukaki, Izolde
    Kallergis, Eleftherios
    Tzanakis, Nikolaos
    Tzortzaki, Eleni
    Vlachaki, Eleni
    Siafakas, Nikolaos M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (11) : 968 - 975
  • [32] Adherence to CPAP therapy: comparing the effect of three educational approaches in patients with obstructive sleep apnoea
    Delanote, Isabelle
    Borzee, Pascal
    Belge, Catharina
    Buyse, Bertien
    Testelmans, Dries
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (01) : 91 - 96
  • [33] Nasal function and CPAP use in patients with obstructive sleep apnoea: a systematic review
    Marina Brimioulle
    Konstantinos Chaidas
    Sleep and Breathing, 2022, 26 : 1321 - 1332
  • [34] Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
    Peker, Yuksel
    Thunstrom, Erik
    Glantz, Helena
    Wegscheider, Karl
    Eulenburg, Christine
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (06)
  • [35] Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea
    Tsai-Yu Wang
    Yu-Lun Lo
    Kang-Yun Lee
    Wen-Te Liu
    Shu-Min Lin
    Ting-Yu Lin
    Yung-Lun Ni
    Chao-Yung Wang
    Shu-Chuan Ho
    Han-Pin Kuo
    Respiratory Research, 14
  • [36] Something is changing in adherence to CPAP therapy: real world data after 1 year of treatment in patients with obstructive sleep apnoea
    Morrone, Elisa
    Giordano, Andrea
    Carli, Sonia
    Visca, Dina
    Rossato, Fabio
    Godio, Massimo
    Paracchini, Elena
    Rossi, Sabrina
    Balbi, Bruno
    Sacco, Carlo
    Braghiroli, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (03)
  • [37] The Treatment of Severe Obstructive Sleep Apnoea with Mandibular Advancement Appliance
    Ozturk, Onder
    Tuna, Suleyman Hakan
    Akkaya, Ahmet
    Kilic, Ozkan
    Sahin, Unal
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2011, 40 (02) : 108 - 110
  • [38] The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
    Ponce, Silvia
    Pastor, Esther
    Orosa, Belen
    Oscullo, Grace
    Catalan, Pablo
    Martinez, Alfonso
    Hernandez, Luis
    Muriel, Alfonso
    Chiner, Eusebi
    Angel Martinez-Garcia, Miguel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (02)
  • [39] Inspiratory muscle dysfunction in patients with severe obstructive sleep apnoea
    Chien, M-Y.
    Wu, Y-T.
    Lee, P-L.
    Chang, Y-J.
    Yang, P-C.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (02) : 373 - 380
  • [40] Comparison of empirical continuous positive airway pressure (CPAP) treatment versus initial portable sleep monitoring followed by CPAP treatment for patients with suspected obstructive sleep apnoea
    To, K. W.
    Chan, W. C.
    Chan, T. O.
    Ngai, J.
    Tung, A.
    Ng, S.
    Choo, K. L.
    Hui, D. S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (06) : E107 - E114